C-Rad AB Class B (DE:24C)
FRANKFURT:24C
Want to see DE:24C full AI Analyst Report?
24C Stock Chart & Stats
€2.83
€0.01(0.40%)
At close: 4:00 PM EST
€2.83
€0.01(0.40%)
Day’s Range― - ―
52-Week Range€2.18 - €3.31
Previous CloseN/A
Volume0.00
Average Volume (3M)162.00
Market Cap
€80.12M
Enterprise Value€676.26M
Total Cash (Recent Filing)€171.20M
Total Debt (Recent Filing)€18.80M
Price to Earnings (P/E)168.7
Beta0.26
Next Earnings
May 06, 2026EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.31
Shares Outstanding32,904,050
10 Day Avg. Volume200
30 Day Avg. Volume162
Financial Highlights & Ratios
PEG Ratio-1.27
Price to Book (P/B)3.12
Price to Sales (P/S)2.45
P/FCF Ratio21.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.13
Revenue Forecast (FY)€41.82M
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet, Low LeverageVery low leverage and materially higher equity provide durable financial flexibility. This balance-sheet strength supports capital expenditure for product development and installations, cushions operating volatility, and enables strategic options (R&D, service investments or selective M&A) without urgent external financing.
High Gross Margins (~65–69%)Sustained gross margins near the mid-60s indicate durable product pricing power and favorable product mix in SGRT and positioning systems. High underlying margins provide a buffer for operating leverage, fund ongoing R&D and service capabilities, and help preserve profitability during cyclical revenue swings.
Improved Operating And Free Cash Flow In 2025Material cash generation in 2025 (operating and free cash flow ~71m) strengthens the company’s ability to self-fund maintenance, service contracts, and incremental installations. Reliable cash inflows support reinvestment in product development and customer support without depending heavily on new external capital.
Bears Say
Sharp Profitability Decline In 2025A marked step-down in margins and net profit in 2025 signals weaker earnings quality and operational pressure. Such a sharp profitability reset can compress returns, limit reinvestment capacity, strain incentive structures, and makes multi-year planning harder until margins prove sustainable again.
Negative Revenue TrendDeclining revenue growth undermines expansion of the installed base and recurring service revenue. Persistent top-line weakness can slow attachment rates for software/service contracts, limit economies of scale, and indicate competitive or adoption headwinds that erode long-term growth prospects.
Uneven Cash Conversion And FCF VolatilityVolatile free cash flow reduces predictability of funding for R&D, upgrades and service expansion. Periods of negative FCF heighten refinancing risk in downturns and constrain the firm’s ability to consistently invest in sales capacity and long-cycle capital items, weakening strategic optionality.
C-Rad AB Class B News
24C FAQ
What was C-Rad AB Class B’s price range in the past 12 months?
C-Rad AB Class B lowest stock price was €2.18 and its highest was €3.31 in the past 12 months.
What is C-Rad AB Class B’s market cap?
C-Rad AB Class B’s market cap is €80.12M.
When is C-Rad AB Class B’s upcoming earnings report date?
C-Rad AB Class B’s upcoming earnings report date is May 06, 2026 which is today.
How were C-Rad AB Class B’s earnings last quarter?
Currently, no data Available
Is C-Rad AB Class B overvalued?
According to Wall Street analysts C-Rad AB Class B’s price is currently Overvalued.
Does C-Rad AB Class B pay dividends?
C-Rad AB Class B does not currently pay dividends.
What is C-Rad AB Class B’s EPS estimate?
C-Rad AB Class B’s EPS estimate is 0.01.
How many shares outstanding does C-Rad AB Class B have?
C-Rad AB Class B has 32,904,050 shares outstanding.
What happened to C-Rad AB Class B’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of C-Rad AB Class B?
Currently, no hedge funds are holding shares in DE:24C
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
C-Rad AB Class B
C-Rad AB (publ), together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. The company operates through two segments, Positioning and Imaging. Its products include Sentinel 4D CT, a laser-based optical surface scanning system; Catalyst, a 4D surface image guided radiation therapy (SIGRT) solution; Catalyst HD, an SIGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; Catalyst+, an SIGRT solution for high precision patient positioning, intra-fraction motion management, and respiratory gating; and Catalyst+ HD, a solution for high precision patient positioning, intra-fraction motion management, and respiratory gating for conventional and stereotactic treatment delivery. The company's products also comprise Catalyst Tomo, an enhanced positioning solution for tomotherapy; Catalyst PT, a real-time tracking solution for particle therapy; Cyrpa laser positioning products; cAccessory, which automates the registration and validation of treatment accessories; and cPatient that automates patient identity validation without the need for contact between patients and devices. In addition, it offers installation, application training, and aftersales services. C-Rad AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.
Technical Analysis
Paxman AB
―
Senzime AB
―
Bactiguard Holding AB
―
Integrum AB Class B
―
Sedana Medical AB
―